Sunday, July 5, 2020

Remdesivir can shorten patient hospital stays, says NIH study

A new NIH trial is suggesting the use of the antiviral drug Remdesivir by Gilead Sciences is improving clinical outcomes. The study published in the New England Journal of Medicine shows that drugs are shortening the recovery period of COVID-19 in patients. The trial involved a total of 1,063 patients who either received the drug intravenously or through a placebo. It was seen the recovery period was fast in patients who received the drug than the placebo population by four days. After obtaining an “emergency use authorization” last month from the FDA, the drug was widely used in critically ill patients to save their lives.

The recovery implies that the patients will be in a condition that they can be discharged from hospitals. The study also showed the drug was beneficial in patients with severe complications of the disease. We see that Hydroxychloroquine trials coming to a halt due to safety concerns. We do not see such upcoming with this drug. Moreover, the drug has positive reviews from the day that we currently have. Therefore, we can see that antiviral drugs can form a major part of the treatment regime in the days.

Read Also: CDC says that the coronavirus doesn’t spread easily on surfaces

However, the study also mentions that there was higher mortality in spite of the treatment. Therefore, the study calls for improving the strategies for the treatment using the drug. The report also concluded that the drug alone isn’t sufficient to treat the disease. This will lead us to new studies in the coming days with the drug that will eventually lead us in combating the disease better.

Do you want to publish on Apple News, Google News, and more? Join our writing community, improve your writing skills, and be read by hundreds of thousands around the world!

Source: Fox News

Comment Below

Featured Stories

Modest alcohol consumption can bring a healthier brain, new study says

The trend towards alcohol is fast growing at the time. It is one of the most popular...

Coronavirus-infected cells grow more branched extensions than normal, new studies reveal

A recent study published in the scientific journal Cell found that infection with the novel coronavirus can...

Latest Stories

Instagram new feature brings follow suggestions to stories

Instagram stories now suggest who to follow, as noted by a member of the News Landed writing...

World record $1 billion worth of ISIS-made drugs buested by Italy

With a plethora of happenings around the world, a drug bust has come into the highlight where...

A 3,000-year-old Egyptian bird mummy examined in Israel

At the Computerized Tomography (CT) Institute at Rambam Hospital in Haifa in the occupied Palestinian territories, there...

Related Stories

The new strain of coronavirus is mutated and more virulent

The current SARS-CoV-2 is said to differ from the originally evolved strain from the Wuhan where disease...

Coronavirus-infected cells grow more branched extensions than normal, new studies reveal

A recent study published in the scientific journal Cell found that infection with the novel coronavirus can...